Jobs at Revolution Medicine (Now Hiring) — 42 open — Page 2
Senior QA Specialist, Quality Systems, GxP Training
Redwood City, California, United States · Hybrid
$90k–$108k/yr
Senior
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: GxP Training, Quality Assurance, Instructional Design, Veeva QualitySuite, Regulatory Compliance
Senior Manager, GxP Electronic System Validation QA
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Computer System Validation, Quality Assurance, GxP Regulations, Data Integrity, FDA 21 CFR Part 11
Senior Director, Access Strategy & Marketing
United States · Remote OK
$232k–$290k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Managed Care Strategy, Product Launch, Market Access, Value Proposition Development, Portfolio Strategy
Senior Director, Access Strategy & Marketing
United States · Remote OK
$232k–$290k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Managed Care Strategy, Market Access, Product Launch, Value Proposition Development, Non-Clinical Positioning
Vice President, Translational Research
Redwood City, California, United States · Hybrid
$294k–$367k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Cancer Pharmacology, Translational Research, PK/PD, In Vivo Pharmacology, AI/ML Integration
Senior QA Specialist, Global Document Control Management
Redwood City, California, United States · Hybrid
$90k–$108k/yr
Senior
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: GxP Document Management, Quality Assurance, Veeva QualitySuite, Document Change Control, Regulatory Compliance
Senior Manager, Medical Excellence and Operations, Japan
Japan · Remote OK
Senior
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Medical Governance, Compliance, Regulatory Affairs, Medical Operations, Contract Management
Senior Director, Country Manager, Netherlands
Amsterdam, North Holland, Netherlands · Hybrid
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Country Management, Oncology Drug Launch, P&L Management, Market Access Strategy, Pricing Strategy
Senior Director, Country Manager, Belgium&Luxembourg
Brussels, Brussels-Capital, Belgium · Hybrid
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Strategy, P&L Management, Oncology Drug Launch, Market Access, Pricing Strategy
Director, Clinical Pharmacology
Redwood City, California, United States · Hybrid
$211k–$264k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Pharmacology, Quantitative Modeling, Translational PK/PD, Population PK, Exposure-Response Analysis
Senior Director, Economic Modeling
Basel, Basel-City, Switzerland · Remote OK
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Economic Modeling, Health Economics, Cost-Effectiveness Analysis, Budget Impact Models, Network Meta-Analysis
Senior Scientist II, Drug Substance
Redwood City, California, United States · On-site
$170k–$212k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Synthetic Organic Chemistry, Process Research And Development, CDMO Management, Quality By Design, Design Of Experiment
Scientist II, Drug Product
Redwood City, California, United States · On-site
$132k–$166k/yr
Mid level
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Drug Product Development, Solid Oral Dosage Forms, Preformulation, Process Scale-up, Technology Transfer
Director, Drug Substance
Redwood City, California, United States · On-site
$211k–$264k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Process Research And Development, Scale-up Manufacturing, Quality By Design, Design Of Experiment, Technology Transfer
Senior Director, Global Finance
United States · Remote OK
$232k–$290k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: International Accounting, Controllership, Finance Operations, Project Management, SOX Compliance
Associate Director, HEOR/RWE GI
United States · Remote OK
$186k–$233k/yr
Senior
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Health Economics, Outcomes Research, Real World Evidence, Patient-Reported Outcomes, Oncology HEOR
Senior Director, Country Manager, Nordics
Copenhagen, Capital Region of Denmark, Denmark · Hybrid
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Strategy, P&L Management, Oncology Drug Launch, Market Access, Pricing Strategy
Senior Director, Country Manager, Austria
Vienna, Austria · Hybrid
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Strategy, P&L Management, Oncology Drug Launch, Market Access, Pricing Strategy
Director, Medical Affairs, Switzerland
Basel, Basel-City, Switzerland · Hybrid
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Medical Affairs Strategy, Oncology, Stakeholder Management, KOL Engagement, Product Launch
Director, Market Access,Switzerland
Basel, Basel-City, Switzerland · Hybrid
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Market Access Strategy, Pricing and Reimbursement, Health Technology Assessment (HTA), Oncology, Stakeholder Management